Caroline Schinke

54PUBLICATIONS
130CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical mycologyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Aug 06, 2026
Talquetamab in patients with relapsed/refractory multiple myeloma: 3-year follow-up of the phase 1/2 MonumenTAL-1 study.

|Jul 28, 2026
Efficacy and Safety of CAR-T Cell Therapy and Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma with Renal Impairment: A Propensity Score-Matched Analysis.

|Jul 21, 2026
Efficacy and safety of BCMA-targeted therapies in relapsed or refractory AL amyloidosis: a descriptive pooled analysis.

|Mar 31, 2026
Clinical outcomes and risk factors of cytomegalovirus reactivation in teclistamab-treated multiple myeloma patients.

Hira Cheema, Asis Shrestha, Syed Naqvi

|Nov 07, 2025
Talquetamab in relapsed refractory multiple myeloma: multi-institutional real-world study.

Samer Al Hadidi, Aniko Szabo, Bhavesh Mohan Lal

|Oct 29, 2025
How Does Age at Diagnosis Influence Multiple Myeloma Survival? Empirical Evidence.

Michael O Lawanson, Ernest Griffin, Daniel Berleant

Pageof 9

Frequent Collaborators

25 joint publications

Frits van Rhee

24 joint publications

Samer Al-Hadidi

17 joint publications

Meera Mohan

10 joint publications

Fenghuang Zhan